Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Bibliographic Details
Main Authors: Sen Miao, Gaoda Ju, Chonghua Jiang, Bing Xue, Lihua Zhao, Rui Zhang, Han Diao, Xingzhou Yu, Linlin Zhang, Xiaozao Pan, Hua Zhang, Lijuan Zang, Lei Wang, Tianhao Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1375203/full
_version_ 1797324134323060736
author Sen Miao
Gaoda Ju
Chonghua Jiang
Bing Xue
Lihua Zhao
Rui Zhang
Han Diao
Xingzhou Yu
Linlin Zhang
Xiaozao Pan
Hua Zhang
Lijuan Zang
Lei Wang
Tianhao Zhou
author_facet Sen Miao
Gaoda Ju
Chonghua Jiang
Bing Xue
Lihua Zhao
Rui Zhang
Han Diao
Xingzhou Yu
Linlin Zhang
Xiaozao Pan
Hua Zhang
Lijuan Zang
Lei Wang
Tianhao Zhou
author_sort Sen Miao
collection DOAJ
first_indexed 2024-03-08T05:45:49Z
format Article
id doaj.art-85b0be2293a54045a4326f25ec370025
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-08T05:45:49Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-85b0be2293a54045a4326f25ec3700252024-02-05T11:47:21ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-02-011110.3389/fmed.2024.13752031375203Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancerSen Miao0Gaoda Ju1Chonghua Jiang2Bing Xue3Lihua Zhao4Rui Zhang5Han Diao6Xingzhou Yu7Linlin Zhang8Xiaozao Pan9Hua Zhang10Lijuan Zang11Lei Wang12Tianhao Zhou13Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, ChinaDepartment of Neurosurgery, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Pathology Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Breast Surgery, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Medical Oncology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chinahttps://www.frontiersin.org/articles/10.3389/fmed.2024.1375203/fullDYNLT1breast cancerbiomarkerprognosisimmune checkpoint blocking therapy
spellingShingle Sen Miao
Gaoda Ju
Chonghua Jiang
Bing Xue
Lihua Zhao
Rui Zhang
Han Diao
Xingzhou Yu
Linlin Zhang
Xiaozao Pan
Hua Zhang
Lijuan Zang
Lei Wang
Tianhao Zhou
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
Frontiers in Medicine
DYNLT1
breast cancer
biomarker
prognosis
immune checkpoint blocking therapy
title Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
title_full Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
title_fullStr Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
title_full_unstemmed Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
title_short Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
title_sort corrigendum identification of dynlt1 associated with proliferation relapse and metastasis in breast cancer
topic DYNLT1
breast cancer
biomarker
prognosis
immune checkpoint blocking therapy
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1375203/full
work_keys_str_mv AT senmiao corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT gaodaju corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT chonghuajiang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT bingxue corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT lihuazhao corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT ruizhang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT handiao corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT xingzhouyu corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT linlinzhang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT xiaozaopan corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT huazhang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT lijuanzang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT leiwang corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer
AT tianhaozhou corrigendumidentificationofdynlt1associatedwithproliferationrelapseandmetastasisinbreastcancer